While the percentage of pDC levels was also similar between cancer patients and healthy donors, cancer patients also had higher levels of PD-L1+ pDCs (p=0.0003, Figure 5G), which can have immunosuppressive and tolerogenic properties [20]. Here, CD274 is linked to cancer.